Integra (IART) CEO receives new RSU and stock option grants

Rhea-AI Filing Summary

Integra LifeSciences Holdings Corp President and CEO Stuart Essig received significant equity awards as compensation. On 6/1/2026, he was granted 365,297 restricted stock units, each representing one share of common stock, and 705,468 non-qualified stock options with a conversion price of $15.6700 per share.

The option award consists of 482,976 options granted under his employment agreement and 222,492 options granted at the Compensation Committee’s discretion. The RSU award consists of 255,265 RSUs under the employment agreement and 110,032 RSUs granted by the Compensation Committee.

All awards were granted under the company’s equity incentive plan and will vest one-third on the first anniversary of 5/1/2026, then in monthly installments over the following twenty-four months, subject to his continued service. These are grants/awards, not open-market purchases or sales.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider ESSIG STUART

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Non-Qualified Stock Option (right to buy)	705,468	$0.00	--
Grant/Award	Restricted Stock Units	365,297	$0.00	--

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 705,468 shares (Direct, null); Restricted Stock Units — 365,297 shares (Direct, null)

Footnotes (1)

1. This award consists of (x) 482,976 stock options granted pursuant to the equity award provisions of the Reporting Person's employment agreement with the Issuer (the "Employment Agreement"), and (y) 222,492 stock options granted at the discretion of the Compensation Committee of the Issuer's Board of Directors (the "Compensation Committee"). All stock options reported in this row were granted under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan") and will vest as to one-third of such stock options on the first anniversary of 5/1/2026 and thereafter in monthly installments through the following twenty-four months, in each case subject to the Reporting Person's continued service through the applicable vesting dates. Grant of restricted stock units ("RSUs") pursuant to the Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. This award consists of (x) 255,265 RSUs granted pursuant to the equity award provisions of the Employment Agreement, and (y) 110,032 RSUs granted at the discretion of the Compensation Committee. All RSUs reported in this row were granted under the Plan and will vest as to one-third of the shares on the first anniversary of 5/1/2026 and thereafter in monthly installments through the following twenty-four months, in each case subject to the Reporting Person's continued service through the applicable vesting dates.

Key Figures

RSU grant size: 365,297 RSUs Option grant size: 705,468 options Option exercise price: $15.6700 per share +5 more

8 metrics

RSU grant size 365,297 RSUs Granted to CEO on 6/1/2026

Option grant size 705,468 options Non-qualified stock options granted 6/1/2026

Option exercise price $15.6700 per share Conversion or exercise price for options

Options from employment agreement 482,976 options Portion of option award under employment agreement

Discretionary options 222,492 options Granted at Compensation Committee’s discretion

RSUs from employment agreement 255,265 RSUs Part of RSU award under employment agreement

Discretionary RSUs 110,032 RSUs Granted at Compensation Committee’s discretion

Option expiration date 2034-06-01 Expiration of non-qualified stock options

Key Terms

Restricted Stock Units, Non-Qualified Stock Option, equity award provisions, Compensation Committee, +2 more

6 terms

Restricted Stock Units financial

"Grant of restricted stock units ("RSUs") pursuant to the Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Non-Qualified Stock Option financial

"Non-Qualified Stock Option (right to buy) with a conversion price of 15.6700."

A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

equity award provisions financial

"stock options granted pursuant to the equity award provisions of the Reporting Person's employment agreement"

Compensation Committee financial

"stock options granted at the discretion of the Compensation Committee of the Issuer's Board of Directors"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

Equity Incentive Plan financial

"granted under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

vesting financial

"will vest as to one-third on the first anniversary of 5/1/2026 and thereafter in monthly installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ESSIG STUART

(Last) (First) (Middle)

1100 CAMPUS ROAD

(Street)

PRINCETON NEW JERSEY 08540

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INTEGRA LIFESCIENCES HOLDINGS CORP [ IART ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$15.67	06/01/2026		A		705,468		(1)	06/01/2034	Common Stock	705,468	$0	705,468	D
Restricted Stock Units	(2)	06/01/2026		A		365,297		(3)	(3)	Common Stock	365,297	$0	365,297	D

Explanation of Responses:

1. This award consists of (x) 482,976 stock options granted pursuant to the equity award provisions of the Reporting Person's employment agreement with the Issuer (the "Employment Agreement"), and (y) 222,492 stock options granted at the discretion of the Compensation Committee of the Issuer's Board of Directors (the "Compensation Committee"). All stock options reported in this row were granted under the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan") and will vest as to one-third of such stock options on the first anniversary of 5/1/2026 and thereafter in monthly installments through the following twenty-four months, in each case subject to the Reporting Person's continued service through the applicable vesting dates.

2. Grant of restricted stock units ("RSUs") pursuant to the Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

3. This award consists of (x) 255,265 RSUs granted pursuant to the equity award provisions of the Employment Agreement, and (y) 110,032 RSUs granted at the discretion of the Compensation Committee. All RSUs reported in this row were granted under the Plan and will vest as to one-third of the shares on the first anniversary of 5/1/2026 and thereafter in monthly installments through the following twenty-four months, in each case subject to the Reporting Person's continued service through the applicable vesting dates.

Remarks:

	/s/ Michael Hutchinson; Attorney-in-Fact for Stuart Essig	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did Integra (IART) CEO Stuart Essig receive?

Stuart Essig received 365,297 restricted stock units and 705,468 non-qualified stock options on 6/1/2026. Each RSU equals one common share, and the options are exercisable at $15.6700 per share under Integra’s equity incentive plan.

How do the new Integra (IART) CEO stock options vest?

The 705,468 stock options vest one-third on the first anniversary of 5/1/2026, then in monthly installments over the next 24 months. Vesting is contingent on Stuart Essig’s continued service with Integra LifeSciences throughout the vesting period.

What are the terms of the new Integra (IART) CEO RSU grant?

The 365,297 RSUs vest one-third on the first anniversary of 5/1/2026, then monthly over the following 24 months. Each restricted stock unit represents a contingent right to receive one share of Integra common stock if service-based conditions are met.

How much of Integra (IART) CEO Essig’s option grant comes from his employment agreement?

Of the 705,468 options, 482,976 were granted under Stuart Essig’s employment agreement and 222,492 were granted at the Compensation Committee’s discretion. All options were issued under Integra’s Fifth Amended and Restated 2003 Equity Incentive Plan.

How is the Integra (IART) CEO RSU grant split between agreement and committee awards?

The RSU award includes 255,265 units granted under Stuart Essig’s employment agreement and 110,032 units granted at the Compensation Committee’s discretion. All RSUs were issued under Integra’s equity incentive plan with the same time-based vesting schedule.

Do the new Integra (IART) CEO grants involve any open-market share purchases or sales?

No, the Form 4 shows only compensation-related equity grants to Stuart Essig. The transactions are classified as grant or award acquisitions, not open-market buying or selling of Integra LifeSciences common stock by the CEO.